Westwood Management Corporation’s NeuBase Therapeutics, Inc. Common Stock NBSE Stock Holding History

Westwood Management Corporation’s Portfolio NBSE Stock Details NBSE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q2	–	Sell	-50	Closed	-$17K	–	87
2017 Q1	$17K	Hold	50	–	–	﹤0.01%	83
2016 Q4	$30K	Hold	50	–	–	0.01%	76
2016 Q3	$57K	Hold	50	–	–	0.01%	78
2016 Q2	$55K	Hold	50	–	–	0.01%	70
2016 Q1	$64K	Hold	50	–	–	0.01%	74
2015 Q4	$123K	Hold	50	–	–	0.02%	72
2015 Q3	$55K	Hold	50	–	–	0.01%	76
2015 Q2	$50K	Hold	50	–	–	0.01%	83
2015 Q1	$51K	Buy	+50	New	+$165K	0.01%	87

Other funds holding NBSE

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

GBA

Garrison Bradford & Associates New York $92.2M AUM 19.08% 1-Year Est. Return

UCFA

United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return

California Public Employees Retirement System Sacramento, California $162B AUM 25.78% 1-Year Est. Return

VKH

Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return

Westwood Management Corporation's NBSE Position: Q2 2017 in Review

Westwood Management Corporation sold out of NeuBase Therapeutics, Inc. Common Stock (NBSE) in Q2 2017, closing a stake of 50 shares — an estimated $17K sold.

Westwood Management Corporation first reported a position in NBSE in Q1 2015 and held it in 9 quarters. The position peaked at $123K in Q4 2015. 38 funds tracked by Wall St. Rank hold NBSE as of Q2 2017.

Westwood Management Corporation reported no remaining NeuBase Therapeutics, Inc. Common Stock position as of Q2 2017 after selling out during the quarter.
Westwood Management Corporation sold 50 NeuBase Therapeutics, Inc. Common Stock shares in Q2 2017, an estimated $17K.
Westwood Management Corporation first reported a position in NeuBase Therapeutics, Inc. Common Stock in Q1 2015 and held it in 9 quarters.
Westwood Management Corporation's NeuBase Therapeutics, Inc. Common Stock position peaked at $123K in Q4 2015.
38 funds tracked by Wall St. Rank held NeuBase Therapeutics, Inc. Common Stock as of Q2 2017.

Based on Westwood Management Corporation's 13F filing for Q2 2017, filed 21 Jul 2017.